Defining Objective Markers of Compliance for Dietary Therapies in IBS | MicrobiomeTrials← Back to trialsNCT07494968
Defining Objective Markers of Compliance for Dietary Therapies in IBS
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-05-11Est. Completion: 2027-12
Enrollment target: 94 participants Locations- University of Michigan, Ann Arbor, Michigan, United States
Other microbiome trials you might be interested in
Functional Somatic DisorderSomatic Symptom Disorder
Functional somatic syndromes (e.g. irritable bowel syndrome, fibromyalgia) and medically unexplained symptoms (e.g. chro…
Stockholm, SwedenCompleted Jun 1, 2024
Irritable Bowel Syndrome
Irritable Bowel Syndrome (IBS), characterized by the Rome IV criteria, is a functional bowel disorder combining abdomina…
Lyon, FranceEst. completion Oct 10, 2028
Completed
Functional Somatic DisorderSomatic Symptom DisorderFunctional Somatic Syndromes
Functional somatic syndromes (e.g. irritable bowel syndrome, fibromyalgia) and medically unexplained symptoms (e.g. chro…
Stockholm, SwedenCompleted Jan 1, 2025